Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry model

• Prif Awduron: Amram Torgeman (Awdur), Arieh Schwartz (Awdur), Eran Diamant (Awdur), Tzadok Baruchi (Awdur), Eyal Dor (Awdur), Alon Ben David (Awdur), Avi Pass (Awdur), Ada Barnea (Awdur), Arnon Tal (Awdur), Amir Rosner (Awdur), Osnat Rosen (Awdur), Ran Zichel (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: The Company of Biologists, 2018-09-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Botulinum neurotoxin (BoNT) serotypes A, B and E are responsible for most cases of human botulism. The only approved therapy for botulism is antitoxin treatment administered to patients after symptom onset. However, a recent meta-analysis of antitoxin efficacy in human botulism cases over the past c...